A real-world study of acute and preventive medication use, adherence, and persistence in patients prescribed fremanezumab in the United States

A real-world study of acute and preventive medication use, adherence, and persistence in patients prescribed fremanezumab in the United States

Abstract Background Following approval of fremanezumab for the prevention of migraine in adults, health care decision makers are interested in understanding real-world clinical characteristics and treatment patterns among patients initiating fremanezumab therapy. Methods Data were obtained for this...

Full description

Bibliographic Details
Main Authors: Lynda J. Krasenbaum, Vasantha L. Pedarla, Stephen F. Thompson, Krishna Tangirala, Joshua M. Cohen, Maurice T. Driessen
Format: Article
Language:English
Published: BMC 2022-05-01
Series:The Journal of Headache and Pain
Subjects:
Fremanezumab
Migraine
Prevention
Real-world data
Adherence
Persistence
Online Access:https://doi.org/10.1186/s10194-022-01413-z

Internet

https://doi.org/10.1186/s10194-022-01413-z

Similar Items